Want to create an interactive transcript for this episode?
Podcast: Surfing the MASH Tsunami
Episode: S5 - E7 - MASLD Patient Advocates Celebrate Rezdiffra and Discuss the Future
Description: Last Thursday, March 14, Rezdiffra (resmetirom) became the first drug approved in the US for MASH. Five leading North American MASLD patient advocates join the Surfers to discuss their feelings about this approval along with the opportunities and challenges that lie ahead.00:00:00 - Surf's Up: Season 5 Episode 7Opening introduction from an excited, enthusiastic panel, including brief quotes taken directly from the episode discussion.00:05:55 - GroundbreakersEach panelist shares one piece of good news from the previous week.00:11:19 - Advocates recall March 14As March 14 progressed, advocates' attitudes moved from excited...